Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQQD5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,802
Award facts
- Contract value 100% obligated
- $41,802.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,802 to DMS Pharmaceutical Group Inc. on January 29, 2026, for Nexplanon 68 mg implants, a subdermal contraceptive device. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, specializing in distributing comprehensive pharmaceutical products and medical consumables to federal agencies, particularly the Department of Defense. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The order is scheduled for ultimate completion by February 20, 2026, and is structured as a firm fixed-price contract.
This award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated contract SPE2DR. The broader PPV-G GEN V is a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to military healthcare facilities worldwide. DMS Pharmaceutical Group's IDC, awarded November 13, 2025, carries a ceiling value of $499,999,999 with completion through December 31, 2036, positioning the company as a critical supplier for Department of Defense healthcare operations and enabling the issuance of firm fixed-price delivery orders for diverse pharmaceutical and medical supply requirements across the military medical system.
Quick answers
Who was awarded contract SPE2DR26FQQD5?
SPE2DR26FQQD5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQQD5 worth?
The government has obligated $41,802 on SPE2DR26FQQD5.
Is contract SPE2DR26FQQD5 an order under another contract?
Yes. SPE2DR26FQQD5 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQQD5 competed?
The extent of competition for SPE2DR26FQQD5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award